×
Quanterix Receivables 2016-2024 | QTRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Quanterix receivables from 2016 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
Quanterix Receivables 2016-2024 | QTRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Quanterix receivables from 2016 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$203.4B
Stryker (SYK)
$148.7B
Boston Scientific (BSX)
$134.9B
EssilorLuxottica (ESLOY)
$111.5B
Medtronic (MDT)
$108.7B
Haleon (HLN)
$43.2B
Lonza Group Ag (LZAGY)
$42.4B
GE HealthCare Technologies (GEHC)
$37.5B
ResMed (RMD)
$35.8B
Terumo (TRUMY)
$29.4B
Koninklijke Philips (PHG)
$24.8B
Zimmer Biomet Holdings (ZBH)
$21.6B
Insulet (PODD)
$18.4B
Baxter (BAX)
$16.8B
Smith & Nephew SNATS (SNN)
$10.9B
BellRing Brands (BRBR)
$9.9B
Bio-Rad Laboratories (BIO)
$9.1B
Demant (WILYY)
$8.3B
Lantheus Holdings (LNTH)
$6.1B
TG Therapeutics (TGTX)
$5.4B
Haemonetics (HAE)
$4.3B
Prestige Consumer Healthcare (PBH)
$4.2B
ICU Medical (ICUI)
$4.1B
Perrigo (PRGO)
$3.7B
Envista Holdings (NVST)
$3.7B
Agios Pharmaceuticals (AGIO)
$3.2B
Neogen (NEOG)
$3.2B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.8B
QuidelOrtho (QDEL)
$2.5B